Literature DB >> 29312705

Anemia as a clinical marker of stable chronic obstructive pulmonary disease in the Korean obstructive lung disease cohort.

Yeon-Mok Oh1, Joo Hun Park2, Eun-Kyung Kim3, Sung Chul Hwang2, Hyun Ji Kim4, Dae Ryong Kang4, Kwang Ha Yoo5, Ji-Hyun Lee3, Tae-Hyung Kim6, Seong Yong Lim7, Chin Kook Rhee8, Hyoung Kyu Yoon8, Sang Yeub Lee9, Sang-Do Lee1.   

Abstract

BACKGROUND: Anemia is a major co-morbidity in chronic obstructive pulmonary disease (COPD). However, the mechanism of development for anemia and the impact of anemia on the prognosis of COPD remain poorly understood. Therefore, this study attempted to evaluate the prognostic role of anemia on the clinical course of COPD and investigate the factors linked with the serum hemoglobin level in COPD.
METHODS: We analyzed 407 COPD patients enrolled in the Korean obstructive lung disease (KOLD) cohort at 16 hospitals in Korea recruited over 9 years. Multivariate Cox regression analysis was performed to find independent predictors of survival and multivariate logistic regression analyses were done to find independent factors.
RESULTS: Anemic COPD were older with lower body mass index (BMI) (P<0.001), lower serum cholesterol level (P=0.001), lower serum albumin level (P<0.001), and shorter 6-minute walking distance (P=0.046) compared to non-anemic COPD. A multivariate Cox regression analysis revealed that age (P=0.002), BMI (P=0.001), post-bronchodilator forced expiratory volume in 1 second (FEV1) (P=0.007), 6-minute walk distance (P=0.008), anemia (P=0.025) were significant predictors for all-cause mortality. In multivariate regression analysis, older age (P<0.001), female gender (P=0.001), lower BMI (P=0.016), and lower serum albumin level (P<0.001) were independent factors associated with lower serum hemoglobin level.
CONCLUSIONS: Our data showed that anemia was an independent risk factor for mortality in COPD, and aging, lower serum albumin level, and lower BMI were independent factors associated with lower serum hemoglobin level.

Entities:  

Keywords:  Chronic obstructive pulmonary disease (COPD); anemia; clinical marker

Year:  2017        PMID: 29312705      PMCID: PMC5757038          DOI: 10.21037/jtd.2017.10.140

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  25 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Independent risk factors for mortality in patients with chronic obstructive pulmonary disease who undergo comprehensive cardiac evaluations.

Authors:  Young-Hwan Ahn; Keu Sung Lee; Joo Hun Park; Jin-Hee Jung; Miyeon Lee; Yun-Jung Jung; Wou Young Chung; Seungsoo Sheen; Kwang Joo Park; Dae Jung Kim; Dae Ryoung Kang; Jeong-Dong Lee; Soojee Yoon; Xiong Jie Jin; Hyoung-Mo Yang; Hong-Seok Lim; Jin Sun Park; Joon-Han Shin; Seung-Jea Tahk
Journal:  Respiration       Date:  2015-08-08       Impact factor: 3.580

3.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung.

Authors:  N Macintyre; R O Crapo; G Viegi; D C Johnson; C P M van der Grinten; V Brusasco; F Burgos; R Casaburi; A Coates; P Enright; P Gustafsson; J Hankinson; R Jensen; R McKay; M R Miller; D Navajas; O F Pedersen; R Pellegrino; J Wanger
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

4.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

5.  Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee.

Authors:  Lorcan P McGarvey; Matthias John; Julie A Anderson; Michael Zvarich; Robert A Wise
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

6.  Haemoglobin level and its clinical impact in a cohort of patients with COPD.

Authors:  C Cote; M D Zilberberg; S H Mody; L J Dordelly; B Celli
Journal:  Eur Respir J       Date:  2007-01-24       Impact factor: 16.671

7.  Anemia and inflammation in COPD.

Authors:  Matthias John; Soeren Hoernig; Wolfram Doehner; Darlington D Okonko; Christian Witt; Stefan D Anker
Journal:  Chest       Date:  2005-03       Impact factor: 9.410

Review 8.  Nutritional supplementation for stable chronic obstructive pulmonary disease.

Authors:  Ivone M Ferreira; Dina Brooks; John White; Roger Goldstein
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

9.  Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron.

Authors:  Donald S Silverberg; Ram Mor; Melanie Tia Weu; Doron Schwartz; Idit F Schwartz; Gil Chernin
Journal:  BMC Pulm Med       Date:  2014-02-24       Impact factor: 3.317

10.  Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria.

Authors:  Yong Il Hwang; Chang Hwan Kim; Hye-Ryun Kang; Taerim Shin; Sang Myeon Park; Seung Hun Jang; Yong Bum Park; Cheol Hong Kim; Dong-Gyu Kim; Myung Goo Lee; In-Gyu Hyun; Ki-Suck Jung
Journal:  J Korean Med Sci       Date:  2009-07-29       Impact factor: 2.153

View more
  2 in total

1.  Blood eosinophil count as a prognostic biomarker in COPD.

Authors:  Yeon-Mok Oh; Keu Sung Lee; Yoonki Hong; Sung Chul Hwang; Jae Yeol Kim; Deog Keom Kim; Kwang Ha Yoo; Ji-Hyun Lee; Tae-Hyung Kim; Seong Yong Lim; Chin Kook Rhee; Hyoung Kyu Yoon; Sang Yeub Lee; Yong Bum Park; Jin Hee Jung; Woo Jin Kim; Sang-Do Lee; Joo Hun Park
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-31

2.  Racial differences in comorbidity profile among patients with chronic obstructive pulmonary disease.

Authors:  Hyun Lee; Sun Hye Shin; Seonhye Gu; Di Zhao; Danbee Kang; Yeong Rae Joi; Gee Young Suh; Roberto Pastor-Barriuso; Eliseo Guallar; Juhee Cho; Hye Yun Park
Journal:  BMC Med       Date:  2018-10-04       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.